BioLife Solutions BLFS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.5M+46.4% | $18.79M-33.1% | $28.07M+10.4% | $25.42M+15.3% | $22.05M+46.0% | ||
| $10M— | —— | —— | —— | $7.25M+18.2% | ||
| $17.5M— | —— | —— | —— | $14.8M+18.2% | ||
| 63.6%— | —— | —— | —— | 67.1%-15.8pp | ||
| $2.65M+279% | $699K-74.2% | $2.71M-0.4% | $2.72M+89.0% | $1.44M— | ||
| $2.53M+26.7% | $1.99M-21.2% | $2.53M-7.5% | $2.73M+11.8% | $2.44M+56.0% | ||
| $12.21M+15.7% | $10.55M-12.6% | $12.07M+5.9% | $11.4M+0.4% | $11.35M-2.0% | ||
| $85K-67.4% | $261K-62.7% | $699K-1.3% | $708K+973% | $66K-93.0% | ||
| $17.47M— | $0-100% | $28.16M-33.1% | $42.06M+175% | $15.3M— | ||
| $27K— | $0+100% | -$89K+99.5% | -$16.64M-3,235% | -$499K— | ||
| 0.1%+0.1pp | 0%+0.3pp | -0.3%+65.2pp | -65.5%-63.2pp | -2.3%— | ||
| $1.04M+25.0% | $833K+64.0% | $508K-25.7% | $684K+0.1% | $683K+1,062% | ||
| $1.22M-39.4% | $2.02M+154% | $792K-14.9% | $931K+18.8% | $784K+1,174% | ||
| $1.25M— | —— | $703K+104% | -$15.71M-5,613% | $285K— | ||
| $62K— | —— | $82K-34.9% | $126K+800% | $14K— | ||
| $1.19M— | —— | $621K+104% | -$15.84M-3,435% | -$448K— | ||
| 4.3%— | —— | 2.2%+64.5pp | -62.3%-60.3pp | -2%— | ||
| $0.02— | —— | $0.01+100% | -$15,838,000.00-158,380,000,100% | $0.01— | ||
| $0-100% | $7.54M— | $0— | $0+100% | -$719K— | ||
| $0.02— | —— | $0.01+103% | -$0.33— | $0.00— | ||
| $0.02— | —— | $0.01+103% | -$0.33-3,200% | -$0.01— | ||
| 49.2M+1.2% | 48.6M-0.2% | 48.7M+1.9% | 47.8M-1.2% | 48.4M+5.0% | ||
| 48.5M+1.5% | 47.8M-0.4% | 47.9M+0.3% | 47.8M+1.4% | 47.1M+2.3% | ||
| $1.04M+25.0% | $833K+64.0% | $508K-25.7% | $684K+0.1% | $683K+1,062% | ||
| $0.02— | —— | $0.01+103% | -$0.33-3,400% | $0.01— | ||
| $0.02— | —— | $0.01+103% | -$0.33-3,400% | $0.01— | ||
| $0— | —— | $0— | —— | -$0.01— | ||
| $1.19M— | —— | $621K+104% | -$15.84M-5,944% | $271K— | ||
| $180K-84.8% | $1.18M+316% | $284K+15.0% | $247K+145% | $101K— | ||
| $27K— | $0+100% | -$89K+99.5% | -$16.64M-3,235% | -$499K-603% | ||
| $401K+53.6% | $261K-52.3% | $547K+103% | -$15.97M-8,826% | $183K-78.9% | ||
| $401K+53.6% | $261K-52.3% | $547K+103% | -$15.97M-8,826% | $183K-78.9% | ||
| 1.5%+0.1pp | 1.4%-0.6pp | 1.9%+64.8pp | -62.8%-63.6pp | 0.8%-4.9pp | ||
| $27K— | $0+100% | -$89K+99.5% | -$16.64M-3,235% | -$499K-603% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioLife Solutions's revenue?
- BioLife Solutions (BLFS) generated $99.8M in revenue over the trailing twelve months, up 27.5% year over year.
- Is BioLife Solutions profitable?
- BioLife Solutions is not currently profitable: it reported a net loss of $14.5M over the trailing twelve months, a -68.7% net margin.
- What are BioLife Solutions's profit margins?
- Gross margin is 66.9% and operating margin is -16.7%, with a -68.7% net margin.
- What is BioLife Solutions's earnings per share?
- BioLife Solutions's diluted EPS over the trailing twelve months is $-0.30.
- Where does BioLife Solutions's income statement data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
